CapVest Acquires Majority Stake in STADA Arzneimittel

September 1, 2025

CapVest Partners LLP has completed its acquisition of a majority stake in STADA Arzneimittel AG, a global healthcare and pharmaceuticals company focused on consumer healthcare, generics, and specialty pharmaceuticals. CapVest and STADA plan to accelerate STADA’s global growth through both organic initiatives and strategic acquisitions.

Buyers
CapVest Partners LLP
Targets
STADA Arzneimittel AG
Sellers
Bain Capital, Cinven
Location
Germany
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.